Patents by Inventor Duncan Armour

Duncan Armour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanin Concentrating Hormone Receptor-1 Antagonist Pyridinones
    Publication number: 20080085884
    Abstract: The present invention provides for MCHR1 antagonist compounds of formula (I) and the pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein the substituents are as defined herein, and the pharmaceutically acceptable salts, solvates and prodrugs thereof, which are useful in treating diseases or conditions wherein antagonism of the MCHR1 receptor is beneficial.
    Type: Application
    Filed: September 27, 2007
    Publication date: April 10, 2008
    Inventors: Duncan Armour, Sebastian Galan, Charlotte Lane, Mark Lansdell, Paul Stupple
  • Triazole compounds useful in therapy
    Patent number: 7084145
    Abstract: The invention provides compounds of formula (I), the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R1, R2, and R7 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V1A antagonists.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: August 1, 2006
    Assignee: Pfizer Inc.
    Inventors: Robert Duncan Armour, Andrew Douglas Baxter, Justin Stephen Bryans, Kevin Neil Dack, Patrick Stephen Johnson, Russell Andrew Lewthwaite, Julie Newman, David James Rawson, Thomas Ryckmans
  • Triazole compounds useful in therapy
    Publication number: 20040162278
    Abstract: The invention provides compounds of formula (I), 1
    Type: Application
    Filed: October 24, 2003
    Publication date: August 19, 2004
    Applicant: Pfizer Inc
    Inventors: Robert Duncan Armour, Andrew Douglas Baxter, Justin Stephen Bryans, Kevin Neil Dack, Patrick Stephen Johnson, Russell Andrew Lewthwaite, Julie Newman, David James Rawson, Thomas Ryckmans
  • Novel pharmaceutical formulation suitable for nebulisation
    Publication number: 20040039020
    Abstract: The present invention relates to a pharmaceutical formulation suitable for nebulisation which comprises an aqueous suspension of (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders such as asthma are also described.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Armour, David Brown, Miles Congreve, Paul Gore, Darren Green, Stuart Holman, Torquil Jack, Steven Keeling, Andrew Mason, Karen Morriss, Nigel Ramsden, Marian Thomas, Peter Ward
  • Novel pharmaceutical formulation suitable for nebulisation
    Publication number: 20040034058
    Abstract: The present invention relates to a pharmaceutical formulation suitable for nebulisation which comprises an aqueous solution of (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders such as asthma are also described.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 19, 2004
    Inventors: Duncan Armour, David Brown, Miles Congreve, Paul Gore, Darren Green, Stuart Holman, Torquil Jack, Andrew Mason, Karen Morriss, Nigel Ramsden, Marian Thomas, Peter Ward